Medicared For All Logo

Venkatadri Beeki MD in Richmond, Missouri

Home Missouri Richmond

Venkatadri Beeki MD has Hematology/oncology as his primary medical specialty. Their primary office is: 904 Wollard Blvd in Richmond, Missouri. There are 4 additional office locations for Venkatadri Beeki MD that can be viewed towards the end of their profile.

They're a part of the: University Of Kansas Hospital Authority medical group which has around 254 members. You can call their office at 913-588-1227 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1985 (around 39 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Venkatadri C Beeki MD Office Phone and Directions

Venkatadri Beeki MD
University Of Kansas Hospital Authority
904 Wollard Blvd
Richmond, Missouri 64085
913-588-1227


Patient Ratings
Please rate your experience with Venkatadri Beeki MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 913-588-1227


Enter a starting address:


Healthcare Info for Venkatadri Beeki MD

Medical School: Sorry, his university is not listed
Graduation Year: 1985
The Primary Medical Specialty for Venkatadri Beeki MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 39
PAC (PECOS ID)#: 7618073925
NPI #: 1619960044
NPI Created On: 08/31/2005
NPI Last Updated Listed as: 12/11/2018
Primary Taxonomy Code: 207RH0003X
License Number:
0429287
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Medica Insurance Company
  • Sunflower State Health Plan, Inc
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. New patient office or other outpatient visit, typically 45 minutes
  2. New patient office or other outpatient visit, typically 45 minutes
  3. New patient office or other outpatient visit, typically 60 minutes
  4. Established patient office or other outpatient visit, typically 15 minutes
  5. Established patient office or other outpatient visit, typically 15 minutes
  6. Established patient office or other outpatient, visit typically 25 minutes
  7. Established patient office or other outpatient, visit typically 25 minutes
  8. Established patient office or other outpatient, visit typically 40 minutes
  9. Initial hospital inpatient care, typically 70 minutes per day
  10. Subsequent hospital inpatient care, typically 25 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788491739

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818766683

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60


Payments Total: $105

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818816043

Being Disputed:: No

Product Related: Yes


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 803171115

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832175461

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832175695

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01


Payments Total: $14

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783643351

Being Disputed:: No

Product Related: No


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832338161

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: TAZVERIK

Open Associated Drug #1: 72607-100-00


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 826451335

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: Kyprolis

Open Associated Drug #1: 76075-101-01


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 843490003

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: LIBTAYO

Open Associated Drug #1: 61755-008-01


Additional Office Locations

1. University Of Kansas Hospital Authority
2800 Clay Edwards Dr
Kansas City, MO 64116
N Ks City Hosp
Group Members: 254

Phone: 913-588-1227

Enter a starting address:


2. University Of Kansas Hospital Authority
2750 Clay Edwards Dr
Kansas City, MO 64116
10 Medical Plaza North U Ks Cncr N Ks Cty
Group Members: 254

Phone: 913-588-1227

Enter a starting address:


3. University Of Kansas Hospital Authority
1000 E 101st Terrace
Kansas City, MO 64131
Univ Ks Cncr Cntr S
Group Members: 254

Phone: 913-588-1227

Enter a starting address:


4. University Of Kansas Hospital Authority
8700 N Green Hiils Rd
Kansas City, MO 64154
Group Members: 254

Phone: 913-588-1227

Enter a starting address:


Providers in University Of Kansas Hospital Authority

1.Saqib Abbasi

4000 Cambridge St
Kansas City Ks 66160-0001
University Of Kansas Hospital Authority
Medical Oncology

2.Al Ola Abdallah

2650 Shawnee Mission Pkwy
Westwood Ks 66205-2003
University Of Kansas Hospital Authority
Hematology

3.Haitham Abdelhakim

2650 Shawnee Mission Pkwy
Westwood Ks 66205-2003
University Of Kansas Hospital Authority
Hematology

4.Sunil Abhyankar Md

3901 Rainbow Blvd
Kansas City Ks 66160-8500
University Of Kansas Hospital Authority
Hematology/oncology

5.Sunil Abhyankar Md

2650 Shawnee Mission Pkwy
Westwood Ks 66205-2003
University Of Kansas Hospital Authority
Hematology/oncology

6.Gareth Agnew

4000 Cambridge St
Kansas City Ks 66160-0001
University Of Kansas Hospital Authority
Nurse Practitioner

View all 254 members of University Of Kansas Hospital Authority medical group